Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines

Authors

Keywords

Journal

Volume 6, Issue 1, Pages 53

Publisher

Springer Nature

Online

2008-09-30

DOI

10.1186/1479-5876-6-53

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started